Pyxis Oncology, Inc. (24)

Browse by Contract Category

Contracts

Letter Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc., dated October 14, 2022 (Filed With SEC on November 1, 2022)
Amended and Restated License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc., dated October 6, 2022 (Filed With SEC on November 1, 2022)
Form of Indemnification Agreement (Filed With SEC on October 4, 2021)
Employment Agreement between Pyxis Oncology, Inc. and Ronald Herbst, Ph.D (Filed With SEC on October 4, 2021)
Pyxis Oncology, Inc. Employee Stock Purchase Plan (Filed With SEC on October 4, 2021)
Lease by and between B9 LS Harrison & Washington LLC and Pyxis Oncology, Inc., dated September 29, 2021 (Filed With SEC on October 1, 2021)
License Agreement, dated March 28, 2022 between the registrant and Biosion USA, Inc (Filed With SEC on May 13, 2022)
Description of registrants securities (Filed With SEC on March 29, 2022)
Employment Agreement between Pyxis Oncology, Inc. and Jay Feingold, M.D (Filed With SEC on October 4, 2021)
Employment Agreement between Pyxis Oncology, Inc. and Pamela Connealy (Filed With SEC on October 4, 2021)
Pyxis Oncology, Inc. 2021 Equity Incentive Plan (Filed With SEC on October 4, 2021)
Employment Agreement between Pyxis Oncology, Inc. and Lara Sullivan, M.D (Filed With SEC on October 4, 2021)
Form of Common Stock Certificate (Filed With SEC on October 4, 2021)
Form of Underwriting Agreement (Filed With SEC on October 4, 2021)
Collaboration Agreement by and among Pyxis Oncology, Inc., Alloy Therapeutics, Inc. and Voxall Therapeutics, LLC., dated March 30, 2021 (Filed With SEC on October 1, 2021)
Amendment to Opt-In, Investment and Additional Consideration Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences, Inc., dated August 2, 2021 (Filed With SEC on October 1, 2021)
Pyxis Oncology, Inc. 2019 Equity Incentive Plan and related form agreements (Filed With SEC on October 1, 2021)
Amended and Restated Investor Rights Agreement, dated March 5, 2021 (Filed With SEC on October 1, 2021)
Amendment No. 1 to License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc (Filed With SEC on September 17, 2021)
Opt-In, Investment and Additional Consideration Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences, Inc (Filed With SEC on September 17, 2021)
First Amendment to License Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences Inc (Filed With SEC on September 17, 2021)
Licensed Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences Inc (Filed With SEC on September 17, 2021)
Exclusive License Agreement between the University of Chicago and Pyxis Oncology for Cancer Immunotherapy Technology (Filed With SEC on September 17, 2021)
License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc (Filed With SEC on September 17, 2021)